BSCL2 p.Val227Phe
c.679G>T · rs1565144788 · VCV581808
Computational evidence
| Protein change | ||
| AlphaMissense | 0.1063 | likely benign |
|---|---|---|
| REVEL | 0.546 | indeterminate |
| SaProt | LLR -7.76 | tolerated |
| ⇒ AlphaMissense and SaProt both call this tolerated; REVEL makes no call. | ||
| Splicing | ||
| SpliceAI | — | not looked up on this page · why |
| Constraint at this position | ||
| Conservation | phyloP 2.1 | GERP -0.021, phastCons 0.97 |
| Regional constraint | o/e 0.60 | unconstrained · MANE · 2,247 bp · p 9.1e-06 · regional, not allelic |
| Overall | ||
| CADD | 19.36 | PHRED · no single calibrated threshold — expert panels disagree |
ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
⚠ Isoform check: AlphaMissense numbered on a different transcript (AM V163F vs ClinVar V227F) — verify the residue.
Population frequency
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- BSCL2
- Protein
- p.Val227Phe
- Coding
- c.679G>T
- dbSNP
- rs1565144788
- Type
- single nucleotide variant
- Location
- chr11:62692749 (GRCh38)
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/bscl2-p-val227phe (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown